Identification of critical regions and candidate genes for Cardiovascular malformations and cardiomyopathy associated with deletions of chromosome 1p36

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zaveri, Hitisha P ^a   Beck, Tyler F ^a   Hernández García, Andrés ^a   Shelly, Katharine E ^a   Montgomery, Tara ^b   Van Haeringen, Arie ^c   Anderlid, Britt Marie ^d   Patel, Chirag ^e   Goel, Himanshu ^f   Houge, Gunnar ^g   Morrow, Bernice E ^h   Cheung, Sau Wai ^a   Lalani, Seema R ^a   Scott, Daryl A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA COARCTATION; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MALFORMATION; CHROMOSOME 1P; CHROMOSOME 1P36; CHROMOSOME DELETION; CLCNKA GENE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY FISTULA; CYTOGENETICS; DVL1 GENE; ECE1 GENE; FALLOT TETRALOGY; GENE; GENETIC ASSOCIATION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HETEROZYGOSITY; HSPG2 GENE; HUMAN; LOSS OF FUNCTION MUTATION; LUZP1 GENE; MAJOR CLINICAL STUDY; MASP2 GENE; PATENT DUCTUS ARTERIOSUS; PDPN GENE; PRDM16 GENE; PRKCZ GENE; PULMONARY VALVE STENOSIS; RERE GENE; SKI GENE; SPEN GENE; UBE4B GENE; WASF2 GENE; CARDIOVASCULAR DISEASE; CHROMOSOME 1; GENE DELETION; GENETICS;

CARDIOVASCULAR ABNORMALITIES; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 1; GENE DELETION; HUMANS;

EID: 84898667019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085600     Document Type: Article

References (47)

1. Shaffer LG, Lupski JR. (2000) Molecular mechanisms f (Pubitemid 32065924)
2. Battaglia A, Hoyme HE, Dallapiccola B, Zackai E, Hudgins L, et al. (2008) Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 121:404-410. (Pubitemid 351198468)
3. Slavotinek A, Shaffer LG, Shapira SK. (1999) Monosomy 1p36. J Med Genet 36:657-663. (Pubitemid 29433722)
4. Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, et al. (2003) Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 72:1200-1212. (Pubitemid 36530007)
5. Kang SH, Scheffer A, Ou Z, Li J, Scaglia F, et al. (2007) Identification of proximal 1p36 deletions using array-CGH: a possible new syndrome. Clin Genet 72:329-338. (Pubitemid 47394224)
6. Nicoulaz A, Rubi F, Lieder L, Wolf R, Goeggel-Simonetti B, et al. (2011) Contiguous approximately 16 Mb 1p36 deletion: Dominant features of classical distal 1p36 monosomy with haplo-lethality. Am J Med Genet A 155A:1964-1968.
7. Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF, et al. (1997) Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 61:642-650. (Pubitemid 27418406)
8. Wu YQ, Heilstedt HA, Bedell JA, May KM, Starkey DE, et al. (1999) Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 8:313-321. (Pubitemid 29054273)
9. Arndt AK, Schafer S, Drenckhahn JD, Sabeh MK, Plovie ER, et al. (2013) Fine Mapping of the 1p36 Deletion Syndrome Identifies Mutation of PRDM16 as a Cause of Cardiomyopathy. Am J Hum Genet 93:67-77.
10. Hofstra RM, Valdenaire O, Arch E, Osinga J, Kroes H, et al. (1999) A loss-offunction mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet 64:304-308. (Pubitemid 30428987)
11. El-Hattab AW, Skorupski JC, Hsieh MH, Breman AM, Patel A, et al. (2010) OEIS complex associated with chromosome 1p36 deletion: a case report and review. Am J Med Genet A 152A:504-511.
12. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, et al. (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366-1373. (Pubitemid 37338337)
13. Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, et al. (2009) Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A 149A:1661-1677.
14. Pizzuti A, Sarkozy A, Newton AL, Conti E, Flex E, et al. (2003) Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot. Hum Mutat 22:372-377. (Pubitemid 37346109)
15. Cremer K, Ludecke HJ, Ruhr F, Wieczorek D. (2008) Left-ventricular noncompaction (LVNC): a clinical feature more often observed in terminal deletion 1p36 than previously expected. Eur J Med Genet 51:685-688.
16. Campeau PM, Ah Mew N, Cartier L, Mackay KL, Shaffer LG, et al. (2008) Prenatal diagnosis of monosomy 1p36: a focus on brain abnormalities and a review of the literature. Am J Med Genet A 146A:3062-3069. (Pubitemid 352774647)
17. Bursztejn AC, Bronner M, Peudenier S, Gregoire MJ, Jonveaux P, et al. (2009) Molecular characterization of a monosomy 1p36 presenting as an Aicardi syndrome phenocopy. Am J Med Genet A 149A:2493-2500.
18. Saito S, Kawamura R, Kosho T, Shimizu T, Aoyama K, et al. (2008) Bilateral perisylvian polymicrogyria, periventricular nodular heterotopia, and left ventricular noncompaction in a girl with 10.5-11.1 Mb terminal deletion of 1p36. Am J Med Genet A 146A:2891-2897.
19. Gajecka M, Saitta SC, Gentles AJ, Campbell L, Ciprero K, et al. (2010) Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpoints. Am J Med Genet A 152A:3074-3083.
20. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, et al. (1997) Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895-905. (Pubitemid 27381628)
21. Etheridge SL, Ray S, Li S, Hamblet NS, Lijam N, et al. (2008) Murine dishevelled 3 functions in redundant pathways with dishevelled 1 and 2 in normal cardiac outflow tract, cochlea, and neural tube development. PLoS Genet 4:e1000259.
22. Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, et al. (2012) Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 44:1249-1254.
23. Zoltewicz JS, Stewart NJ, Leung R, Peterson AS. (2004) Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis. Development 131:3-14. (Pubitemid 38111411)
24. Kim BJ, Zaveri HP, Shchelochkov OA, Yu Z, Hernandez-Garcia A, et al. (2013) An Allelic Series of Mice Reveals a Role for RERE in the Development of Multiple Organs Affected in Chromosome 1p36 Deletions. PLoS One 8:e57460.
25. Mahtab EA, Wijffels MC, Van Den Akker NM, Hahurij ND, Lie-Venema H, et al. (2008) Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: Correlation with abnormal epicardial development. Dev Dyn 237:847-857. (Pubitemid 351398050)
26. Douglas YL, Mahtab EA, Jongbloed MR, Uhrin P, Zaujec J, et al. (2009) Pulmonary vein, dorsal atrial wall and atrial septum abnormalities in podoplanin knockout mice with disturbed posterior heart field contribution. Pediatr Res 65:27-32.
27. Mahtab EA, Vicente-Steijn R, Hahurij ND, Jongbloed MR, Wisse LJ, et al. (2009) Podoplanin deficient mice show a RhoA-related hypoplasia of the sinus venosus myocardium including the sinoatrial node. Dev Dyn 238:183-193.
28. Kuroda K, Han H, Tani S, Tanigaki K, Tun T, et al. (2003) Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 18:301-312. (Pubitemid 36263003)
29. Cappola TP, Matkovich SJ, Wang W, Van Booven D, Li M, et al. (2011) Loss-offunction DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation. Proc Natl Acad Sci U S A 108:2456-2461.
30. Yanagisawa H, Hammer RE, Richardson JA, Williams SC, Clouthier DE, et al. (1998) Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102:22-33. (Pubitemid 28323826)
31. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, et al. (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-836. (Pubitemid 28142825)
32. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, et al. (2002) Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91:158-164. (Pubitemid 34827227)
33. Arikawa-Hirasawa E, Wilcox WR, Le AH, Silverman N, Govindraj P, et al. (2001) Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat Genet 27:431-434. (Pubitemid 32268426)
34. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, et al. (2000) Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26:480-483.
35. Hsu CY, Chang NC, Lee MW, Lee KH, Sun DS, et al. (2008) LUZP deficiency affects neural tube closure during brain development. Biochem Biophys Res Commun 376:466-471.
36. Yamazaki D, Suetsugu S, Miki H, Kataoka Y, Nishikawa S, et al. (2003) WAVE2 is required for directed cell migration and cardiovascular development. Nature 424:452-456. (Pubitemid 36917496)
37. Wu SC, Solaro RJ. (2007) Protein kinase C zeta. A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins. J Biol Chem 282:30691-30698. (Pubitemid 350035228)
38. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, et al. (2008) Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117:2893-2901. (Pubitemid 351787074)
39. Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, et al. (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86:452-460.
40. Hershberger RE, Pinto JR, Parks SB, Kushner JD, Li D, et al. (2009) Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet 2:306-313.
41. Peddy SB, Vricella LA, Crosson JE, Oswald GL, Cohn RD, et al. (2006) Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics 117:1830-1833. (Pubitemid 46071419)
42. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, et al. (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701-712.
43. Bjork BC, Turbe-Doan A, Prysak M, Herron BJ, Beier DR. (2010) Prdm16 is required for normal palatogenesis in mice. Hum Mol Genet 19:774-789.
44. Herron BJ, Lu W, Rao C, Liu S, Peters H, et al. (2002) Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat Genet 30:185-189.
45. Kaneko-Oshikawa C, Nakagawa T, Yamada M, Yoshikawa H, Matsumoto M, et al. (2005) Mammalian E4 is required for cardiac development and maintenance of the nervous system. Mol Cell Biol 25:10953-10964. (Pubitemid 41747138)
46. Boldt AB, Luz PR, Messias-Reason IJ. (2011) MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 140:63-70.
47. Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, et al. (2011) Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 108:7523-7528.